Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan T Nurden

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Rare Diseases (Austin, Tex.)|July 9, 2014
The Nbeal2(-/-) mouse as a model for the gray platelet syndromeCarsten Deppermann, Paquita Nurden, Alan T Nurden, et al.
Thrombosis and Haemostasis|December 24, 2003
Autologous platelets as a source of proteins for healing and tissue regenerationEduardo Anitua, Isabel Andia, Bruno Ardanza, et al.
Biomaterials|December 1, 2018
Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrinEduardo Anitua, Paquita Nurden, Roberto Prado, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Platelets and wound healingAlan T Nurden, Paquita Nurden, Mikel Sanchez, et al.
Platelets|March 8, 2012
A novel amino acid substitution of integrin αIIb in Glanzmann thrombasthenia confirms that the N-terminal region of the receptor plays a role in maintaining β-propeller structureXavier Pillois, Mathieu Fiore, Roland Heilig, et al.
Blood|February 26, 2005
Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIIIHelen Yarovoi, Alan T Nurden, Robert R Montgomery, et al.
Trends in Biotechnology|March 17, 2006
New insights into and novel applications for platelet-rich fibrin therapiesEduardo Anitua, Mikel Sánchez, Alan T Nurden, et al.
British Journal of Haematology|August 30, 2002
A Ser752-->Pro substitution in the cytoplasmic domain of beta3 in a Glanzmann thrombasthenia variant fails to prevent interactions between the alphaIIbbeta3 integrin and the platelet granule pool of fibrinogenPaquita Nurden, Christel Poujol, Joelle Winckler, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2019
A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopeniaBenoit Guillet, Sophie Bayart, Xavier Pillois, et al.
Plos One|November 16, 2013
Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expressionMichel Laguerre, Essa Sabi, Martina Daly, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Rare Diseases (Austin, Tex.)|July 9, 2014
The Nbeal2(-/-) mouse as a model for the gray platelet syndromeCarsten Deppermann, Paquita Nurden, Alan T Nurden, et al.
Thrombosis and Haemostasis|December 24, 2003
Autologous platelets as a source of proteins for healing and tissue regenerationEduardo Anitua, Isabel Andia, Bruno Ardanza, et al.
Biomaterials|December 1, 2018
Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrinEduardo Anitua, Paquita Nurden, Roberto Prado, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Platelets and wound healingAlan T Nurden, Paquita Nurden, Mikel Sanchez, et al.
Platelets|March 8, 2012
A novel amino acid substitution of integrin αIIb in Glanzmann thrombasthenia confirms that the N-terminal region of the receptor plays a role in maintaining β-propeller structureXavier Pillois, Mathieu Fiore, Roland Heilig, et al.
Blood|February 26, 2005
Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIIIHelen Yarovoi, Alan T Nurden, Robert R Montgomery, et al.
Trends in Biotechnology|March 17, 2006
New insights into and novel applications for platelet-rich fibrin therapiesEduardo Anitua, Mikel Sánchez, Alan T Nurden, et al.
British Journal of Haematology|August 30, 2002
A Ser752-->Pro substitution in the cytoplasmic domain of beta3 in a Glanzmann thrombasthenia variant fails to prevent interactions between the alphaIIbbeta3 integrin and the platelet granule pool of fibrinogenPaquita Nurden, Christel Poujol, Joelle Winckler, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2019
A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopeniaBenoit Guillet, Sophie Bayart, Xavier Pillois, et al.
Plos One|November 16, 2013
Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expressionMichel Laguerre, Essa Sabi, Martina Daly, et al.
Pageof 11